Table 1 Characteristics of patients and tumors according to the type of treatment (3D-CRT versus IMRT)
3D-CRT (n= 27) | IMRT (n= 24) | Total (n= 51) | p-value Chi2 | ||
|---|---|---|---|---|---|
Age | Median | 36.1 [40.7-92.2] | 59.7 [49.8-88.1] | 60.8 [40.7-92.2] | 0.2575 |
Sex | Male | 8 (29.6%) | 8 (33.3%) | 16 (31.4%) | 0.776 |
Female | 19 (70.4%) | 16 (66.7%) | 35 (68.6%) | ||
HIV | No | 8 (88.9%) | 9 (100%) | 17 (94.4%) | 1 |
Yes | 1 (11.1%) | 1 (5.6%) | |||
WHO | 0 | 13 (54.2%) | 18 (78.3%) | 31 (66%) | 0.233 |
1 | 8 (33.3%) | 4 (17.4%) | 12 (25.5%) | ||
2 | 3 (12.5%) | 1 (4.4%) | 4 (8.5%) | ||
T-stage | T1/T2/Tis | 12 (44.4%) | 11 (47.8%) | 23 (46%) | |
T3/T4 | 15 (55.6%) | 12 (52.2%) | 27 (54%) | 0.811 | |
Tx | 0 | 1 (4.2%) | 1 (2%) | ||
N-stage | N0 | 17 (65.4%) | 10 (41.7%) | 27 (54%) | 0.093 |
N1/N2/N3 | 9 (34.6%) | 14 (58.3%) | 23 (46%) | ||
Nx | 1 (3.7%) | 0 | 1 (2%) | ||
Histology | Squamous cell | 23 (85.2%) | 22 (91.7%) | 45 (88.2%) | 0.671 |
Others | 4 (14.8%) | 2 (8.3%) | 6 (11.8%) |